ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amyloidosis Therapeutics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-25B13770
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Amyloidosis Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Amyloidosis Therapeutics Market Research Report 2025

Code: QYRE-Auto-25B13770
Report
September 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
ProteoTech, Inc.
Arcturus Therapeutics Inc
BELLUS Health Inc
Celgene Corporation
Millennium Pharmaceuticals Inc
GlaxoSmithKline PLC
Isis Pharmaceuticals, Inc.
Prothena Corporation Plc
SOM Innovation Biotech SL
Alnylam Pharmaceuticals Inc
Onyx Pharmaceuticals, Inc.
Bsim2

Amyloidosis Therapeutics Market Size

The global market for Amyloidosis Therapeutics was valued at US$ 5089 million in the year 2024 and is projected to reach a revised size of US$ 7244 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Amyloidosis Therapeutics Market

Amyloidosis Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Amyloidosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amyloidosis Therapeutics.
The Amyloidosis Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amyloidosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amyloidosis Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Amyloidosis Therapeutics Market Report

Report Metric Details
Report Name Amyloidosis Therapeutics Market
Accounted market size in year US$ 5089 million
Forecasted market size in 2031 US$ 7244 million
CAGR 5.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • AG-10
  • ALN-ANG
  • ALN-TTRsc02
  • CAEL-101
  • Canakinumab
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer Inc., ProteoTech, Inc., Alnylam Pharmaceuticals, Inc., Arcturus Therapeutics, Inc, Bellus Health Inc., Bsim2, Celgene Corporation, Millennium Pharmaceuticals, Inc., Onyx Pharmaceuticals, Inc., GlaxoSmithKline Plc, Isis Pharmaceuticals, Inc., Prothena Corporation Plc, SOM Innovation Biotech SL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Amyloidosis Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Amyloidosis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Amyloidosis Therapeutics Market growing?

Ans: The Amyloidosis Therapeutics Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Amyloidosis Therapeutics Market size in 2031?

Ans: The Amyloidosis Therapeutics Market size in 2031 will be US$ 7244 million.

Who are the main players in the Amyloidosis Therapeutics Market report?

Ans: The main players in the Amyloidosis Therapeutics Market are Pfizer Inc., ProteoTech, Inc., Alnylam Pharmaceuticals, Inc., Arcturus Therapeutics, Inc, Bellus Health Inc., Bsim2, Celgene Corporation, Millennium Pharmaceuticals, Inc., Onyx Pharmaceuticals, Inc., GlaxoSmithKline Plc, Isis Pharmaceuticals, Inc., Prothena Corporation Plc, SOM Innovation Biotech SL

What are the Application segmentation covered in the Amyloidosis Therapeutics Market report?

Ans: The Applications covered in the Amyloidosis Therapeutics Market report are AL Amyloidosis, AA Amyloidoses, ATTR Amyloidoses, Others

What are the Type segmentation covered in the Amyloidosis Therapeutics Market report?

Ans: The Types covered in the Amyloidosis Therapeutics Market report are AG-10, ALN-ANG, ALN-TTRsc02, CAEL-101, Canakinumab, Others

Recommended Reports

Amyloidosis Related

Rare Disease Therapy

Therapeutics & Treatment

1 Amyloidosis Therapeutics Market Overview
1.1 Product Definition
1.2 Amyloidosis Therapeutics by Type
1.2.1 Global Amyloidosis Therapeutics Market Value Comparison by Type (2024 VS 2031)
1.2.2 AG-10
1.2.3 ALN-ANG
1.2.4 ALN-TTRsc02
1.2.5 CAEL-101
1.2.6 Canakinumab
1.2.7 Others
1.3 Amyloidosis Therapeutics by Application
1.3.1 Global Amyloidosis Therapeutics Market Value by Application (2024 VS 2031)
1.3.2 AL Amyloidosis
1.3.3 AA Amyloidoses
1.3.4 ATTR Amyloidoses
1.3.5 Others
1.4 Global Amyloidosis Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Amyloidosis Therapeutics Revenue 2020-2031
1.4.2 Global Amyloidosis Therapeutics Sales 2020-2031
1.4.3 Global Amyloidosis Therapeutics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Amyloidosis Therapeutics Market Competition by Manufacturers
2.1 Global Amyloidosis Therapeutics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Amyloidosis Therapeutics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Amyloidosis Therapeutics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Amyloidosis Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amyloidosis Therapeutics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amyloidosis Therapeutics, Product Type & Application
2.7 Global Key Manufacturers of Amyloidosis Therapeutics, Date of Enter into This Industry
2.8 Global Amyloidosis Therapeutics Market Competitive Situation and Trends
2.8.1 Global Amyloidosis Therapeutics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Amyloidosis Therapeutics Players Market Share by Revenue
2.8.3 Global Amyloidosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Amyloidosis Therapeutics Market Scenario by Region
3.1 Global Amyloidosis Therapeutics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Amyloidosis Therapeutics Sales by Region: 2020-2031
3.2.1 Global Amyloidosis Therapeutics Sales by Region: 2020-2025
3.2.2 Global Amyloidosis Therapeutics Sales by Region: 2026-2031
3.3 Global Amyloidosis Therapeutics Revenue by Region: 2020-2031
3.3.1 Global Amyloidosis Therapeutics Revenue by Region: 2020-2025
3.3.2 Global Amyloidosis Therapeutics Revenue by Region: 2026-2031
3.4 North America Amyloidosis Therapeutics Market Facts & Figures by Country
3.4.1 North America Amyloidosis Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Amyloidosis Therapeutics Sales by Country (2020-2031)
3.4.3 North America Amyloidosis Therapeutics Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amyloidosis Therapeutics Market Facts & Figures by Country
3.5.1 Europe Amyloidosis Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Amyloidosis Therapeutics Sales by Country (2020-2031)
3.5.3 Europe Amyloidosis Therapeutics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amyloidosis Therapeutics Market Facts & Figures by Region
3.6.1 Asia Pacific Amyloidosis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Amyloidosis Therapeutics Sales by Region (2020-2031)
3.6.3 Asia Pacific Amyloidosis Therapeutics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amyloidosis Therapeutics Market Facts & Figures by Country
3.7.1 Latin America Amyloidosis Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Amyloidosis Therapeutics Sales by Country (2020-2031)
3.7.3 Latin America Amyloidosis Therapeutics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amyloidosis Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa Amyloidosis Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Amyloidosis Therapeutics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Amyloidosis Therapeutics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amyloidosis Therapeutics Sales by Type (2020-2031)
4.1.1 Global Amyloidosis Therapeutics Sales by Type (2020-2025)
4.1.2 Global Amyloidosis Therapeutics Sales by Type (2026-2031)
4.1.3 Global Amyloidosis Therapeutics Sales Market Share by Type (2020-2031)
4.2 Global Amyloidosis Therapeutics Revenue by Type (2020-2031)
4.2.1 Global Amyloidosis Therapeutics Revenue by Type (2020-2025)
4.2.2 Global Amyloidosis Therapeutics Revenue by Type (2026-2031)
4.2.3 Global Amyloidosis Therapeutics Revenue Market Share by Type (2020-2031)
4.3 Global Amyloidosis Therapeutics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Amyloidosis Therapeutics Sales by Application (2020-2031)
5.1.1 Global Amyloidosis Therapeutics Sales by Application (2020-2025)
5.1.2 Global Amyloidosis Therapeutics Sales by Application (2026-2031)
5.1.3 Global Amyloidosis Therapeutics Sales Market Share by Application (2020-2031)
5.2 Global Amyloidosis Therapeutics Revenue by Application (2020-2031)
5.2.1 Global Amyloidosis Therapeutics Revenue by Application (2020-2025)
5.2.2 Global Amyloidosis Therapeutics Revenue by Application (2026-2031)
5.2.3 Global Amyloidosis Therapeutics Revenue Market Share by Application (2020-2031)
5.3 Global Amyloidosis Therapeutics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Company Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Amyloidosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Inc. Amyloidosis Therapeutics Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 ProteoTech, Inc.
6.2.1 ProteoTech, Inc. Company Information
6.2.2 ProteoTech, Inc. Description and Business Overview
6.2.3 ProteoTech, Inc. Amyloidosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 ProteoTech, Inc. Amyloidosis Therapeutics Product Portfolio
6.2.5 ProteoTech, Inc. Recent Developments/Updates
6.3 Alnylam Pharmaceuticals, Inc.
6.3.1 Alnylam Pharmaceuticals, Inc. Company Information
6.3.2 Alnylam Pharmaceuticals, Inc. Description and Business Overview
6.3.3 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Portfolio
6.3.5 Alnylam Pharmaceuticals, Inc. Recent Developments/Updates
6.4 Arcturus Therapeutics, Inc
6.4.1 Arcturus Therapeutics, Inc Company Information
6.4.2 Arcturus Therapeutics, Inc Description and Business Overview
6.4.3 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Product Portfolio
6.4.5 Arcturus Therapeutics, Inc Recent Developments/Updates
6.5 Bellus Health Inc.
6.5.1 Bellus Health Inc. Company Information
6.5.2 Bellus Health Inc. Description and Business Overview
6.5.3 Bellus Health Inc. Amyloidosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bellus Health Inc. Amyloidosis Therapeutics Product Portfolio
6.5.5 Bellus Health Inc. Recent Developments/Updates
6.6 Bsim2
6.6.1 Bsim2 Company Information
6.6.2 Bsim2 Description and Business Overview
6.6.3 Bsim2 Amyloidosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bsim2 Amyloidosis Therapeutics Product Portfolio
6.6.5 Bsim2 Recent Developments/Updates
6.7 Celgene Corporation
6.7.1 Celgene Corporation Company Information
6.7.2 Celgene Corporation Description and Business Overview
6.7.3 Celgene Corporation Amyloidosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Celgene Corporation Amyloidosis Therapeutics Product Portfolio
6.7.5 Celgene Corporation Recent Developments/Updates
6.8 Millennium Pharmaceuticals, Inc.
6.8.1 Millennium Pharmaceuticals, Inc. Company Information
6.8.2 Millennium Pharmaceuticals, Inc. Description and Business Overview
6.8.3 Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Portfolio
6.8.5 Millennium Pharmaceuticals, Inc. Recent Developments/Updates
6.9 Onyx Pharmaceuticals, Inc.
6.9.1 Onyx Pharmaceuticals, Inc. Company Information
6.9.2 Onyx Pharmaceuticals, Inc. Description and Business Overview
6.9.3 Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Portfolio
6.9.5 Onyx Pharmaceuticals, Inc. Recent Developments/Updates
6.10 GlaxoSmithKline Plc
6.10.1 GlaxoSmithKline Plc Company Information
6.10.2 GlaxoSmithKline Plc Description and Business Overview
6.10.3 GlaxoSmithKline Plc Amyloidosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GlaxoSmithKline Plc Amyloidosis Therapeutics Product Portfolio
6.10.5 GlaxoSmithKline Plc Recent Developments/Updates
6.11 Isis Pharmaceuticals, Inc.
6.11.1 Isis Pharmaceuticals, Inc. Company Information
6.11.2 Isis Pharmaceuticals, Inc. Description and Business Overview
6.11.3 Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Portfolio
6.11.5 Isis Pharmaceuticals, Inc. Recent Developments/Updates
6.12 Prothena Corporation Plc
6.12.1 Prothena Corporation Plc Company Information
6.12.2 Prothena Corporation Plc Description and Business Overview
6.12.3 Prothena Corporation Plc Amyloidosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Prothena Corporation Plc Amyloidosis Therapeutics Product Portfolio
6.12.5 Prothena Corporation Plc Recent Developments/Updates
6.13 SOM Innovation Biotech SL
6.13.1 SOM Innovation Biotech SL Company Information
6.13.2 SOM Innovation Biotech SL Description and Business Overview
6.13.3 SOM Innovation Biotech SL Amyloidosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.13.4 SOM Innovation Biotech SL Amyloidosis Therapeutics Product Portfolio
6.13.5 SOM Innovation Biotech SL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amyloidosis Therapeutics Industry Chain Analysis
7.2 Amyloidosis Therapeutics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amyloidosis Therapeutics Production Mode & Process Analysis
7.4 Amyloidosis Therapeutics Sales and Marketing
7.4.1 Amyloidosis Therapeutics Sales Channels
7.4.2 Amyloidosis Therapeutics Distributors
7.5 Amyloidosis Therapeutics Customer Analysis
8 Amyloidosis Therapeutics Market Dynamics
8.1 Amyloidosis Therapeutics Industry Trends
8.2 Amyloidosis Therapeutics Market Drivers
8.3 Amyloidosis Therapeutics Market Challenges
8.4 Amyloidosis Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
ProteoTech, Inc.
Arcturus Therapeutics Inc
BELLUS Health Inc
Celgene Corporation
Millennium Pharmaceuticals Inc
GlaxoSmithKline PLC
Isis Pharmaceuticals, Inc.
Prothena Corporation Plc
SOM Innovation Biotech SL
Alnylam Pharmaceuticals Inc
Onyx Pharmaceuticals, Inc.
Bsim2
List of Tables
 Table 1. Global Amyloidosis Therapeutics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Amyloidosis Therapeutics Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Amyloidosis Therapeutics Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Amyloidosis Therapeutics Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Amyloidosis Therapeutics Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Amyloidosis Therapeutics Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Amyloidosis Therapeutics Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Amyloidosis Therapeutics Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Amyloidosis Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Amyloidosis Therapeutics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Amyloidosis Therapeutics, Product Type & Application
 Table 12. Global Key Manufacturers of Amyloidosis Therapeutics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Amyloidosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyloidosis Therapeutics as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Amyloidosis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Amyloidosis Therapeutics Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Amyloidosis Therapeutics Sales Market Share by Region (2020-2025)
 Table 19. Global Amyloidosis Therapeutics Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Amyloidosis Therapeutics Sales Market Share by Region (2026-2031)
 Table 21. Global Amyloidosis Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Amyloidosis Therapeutics Revenue Market Share by Region (2020-2025)
 Table 23. Global Amyloidosis Therapeutics Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Amyloidosis Therapeutics Revenue Market Share by Region (2026-2031)
 Table 25. North America Amyloidosis Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Amyloidosis Therapeutics Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Amyloidosis Therapeutics Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Amyloidosis Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Amyloidosis Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Amyloidosis Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Amyloidosis Therapeutics Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Amyloidosis Therapeutics Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Amyloidosis Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Amyloidosis Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Amyloidosis Therapeutics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Amyloidosis Therapeutics Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Amyloidosis Therapeutics Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Amyloidosis Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Amyloidosis Therapeutics Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Amyloidosis Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Amyloidosis Therapeutics Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Amyloidosis Therapeutics Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Amyloidosis Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Amyloidosis Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Amyloidosis Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Amyloidosis Therapeutics Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Amyloidosis Therapeutics Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Amyloidosis Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Amyloidosis Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Amyloidosis Therapeutics Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Amyloidosis Therapeutics Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Amyloidosis Therapeutics Sales Market Share by Type (2020-2025)
 Table 53. Global Amyloidosis Therapeutics Sales Market Share by Type (2026-2031)
 Table 54. Global Amyloidosis Therapeutics Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Amyloidosis Therapeutics Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Amyloidosis Therapeutics Revenue Market Share by Type (2020-2025)
 Table 57. Global Amyloidosis Therapeutics Revenue Market Share by Type (2026-2031)
 Table 58. Global Amyloidosis Therapeutics Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Amyloidosis Therapeutics Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Amyloidosis Therapeutics Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Amyloidosis Therapeutics Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Amyloidosis Therapeutics Sales Market Share by Application (2020-2025)
 Table 63. Global Amyloidosis Therapeutics Sales Market Share by Application (2026-2031)
 Table 64. Global Amyloidosis Therapeutics Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Amyloidosis Therapeutics Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Amyloidosis Therapeutics Revenue Market Share by Application (2020-2025)
 Table 67. Global Amyloidosis Therapeutics Revenue Market Share by Application (2026-2031)
 Table 68. Global Amyloidosis Therapeutics Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Amyloidosis Therapeutics Price (USD/Pcs) by Application (2026-2031)
 Table 70. Pfizer Inc. Company Information
 Table 71. Pfizer Inc. Description and Business Overview
 Table 72. Pfizer Inc. Amyloidosis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Pfizer Inc. Amyloidosis Therapeutics Product
 Table 74. Pfizer Inc. Recent Developments/Updates
 Table 75. ProteoTech, Inc. Company Information
 Table 76. ProteoTech, Inc. Description and Business Overview
 Table 77. ProteoTech, Inc. Amyloidosis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. ProteoTech, Inc. Amyloidosis Therapeutics Product
 Table 79. ProteoTech, Inc. Recent Developments/Updates
 Table 80. Alnylam Pharmaceuticals, Inc. Company Information
 Table 81. Alnylam Pharmaceuticals, Inc. Description and Business Overview
 Table 82. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Product
 Table 84. Alnylam Pharmaceuticals, Inc. Recent Developments/Updates
 Table 85. Arcturus Therapeutics, Inc Company Information
 Table 86. Arcturus Therapeutics, Inc Description and Business Overview
 Table 87. Arcturus Therapeutics, Inc Amyloidosis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Arcturus Therapeutics, Inc Amyloidosis Therapeutics Product
 Table 89. Arcturus Therapeutics, Inc Recent Developments/Updates
 Table 90. Bellus Health Inc. Company Information
 Table 91. Bellus Health Inc. Description and Business Overview
 Table 92. Bellus Health Inc. Amyloidosis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Bellus Health Inc. Amyloidosis Therapeutics Product
 Table 94. Bellus Health Inc. Recent Developments/Updates
 Table 95. Bsim2 Company Information
 Table 96. Bsim2 Description and Business Overview
 Table 97. Bsim2 Amyloidosis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Bsim2 Amyloidosis Therapeutics Product
 Table 99. Bsim2 Recent Developments/Updates
 Table 100. Celgene Corporation Company Information
 Table 101. Celgene Corporation Description and Business Overview
 Table 102. Celgene Corporation Amyloidosis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Celgene Corporation Amyloidosis Therapeutics Product
 Table 104. Celgene Corporation Recent Developments/Updates
 Table 105. Millennium Pharmaceuticals, Inc. Company Information
 Table 106. Millennium Pharmaceuticals, Inc. Description and Business Overview
 Table 107. Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Product
 Table 109. Millennium Pharmaceuticals, Inc. Recent Developments/Updates
 Table 110. Onyx Pharmaceuticals, Inc. Company Information
 Table 111. Onyx Pharmaceuticals, Inc. Description and Business Overview
 Table 112. Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Product
 Table 114. Onyx Pharmaceuticals, Inc. Recent Developments/Updates
 Table 115. GlaxoSmithKline Plc Company Information
 Table 116. GlaxoSmithKline Plc Description and Business Overview
 Table 117. GlaxoSmithKline Plc Amyloidosis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. GlaxoSmithKline Plc Amyloidosis Therapeutics Product
 Table 119. GlaxoSmithKline Plc Recent Developments/Updates
 Table 120. Isis Pharmaceuticals, Inc. Company Information
 Table 121. Isis Pharmaceuticals, Inc. Description and Business Overview
 Table 122. Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Product
 Table 124. Isis Pharmaceuticals, Inc. Recent Developments/Updates
 Table 125. Prothena Corporation Plc Company Information
 Table 126. Prothena Corporation Plc Description and Business Overview
 Table 127. Prothena Corporation Plc Amyloidosis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Prothena Corporation Plc Amyloidosis Therapeutics Product
 Table 129. Prothena Corporation Plc Recent Developments/Updates
 Table 130. SOM Innovation Biotech SL Company Information
 Table 131. SOM Innovation Biotech SL Description and Business Overview
 Table 132. SOM Innovation Biotech SL Amyloidosis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. SOM Innovation Biotech SL Amyloidosis Therapeutics Product
 Table 134. SOM Innovation Biotech SL Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Amyloidosis Therapeutics Distributors List
 Table 138. Amyloidosis Therapeutics Customers List
 Table 139. Amyloidosis Therapeutics Market Trends
 Table 140. Amyloidosis Therapeutics Market Drivers
 Table 141. Amyloidosis Therapeutics Market Challenges
 Table 142. Amyloidosis Therapeutics Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Amyloidosis Therapeutics
 Figure 2. Global Amyloidosis Therapeutics Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Amyloidosis Therapeutics Market Share by Type: 2024 & 2031
 Figure 4. AG-10 Product Picture
 Figure 5. ALN-ANG Product Picture
 Figure 6. ALN-TTRsc02 Product Picture
 Figure 7. CAEL-101 Product Picture
 Figure 8. Canakinumab Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Amyloidosis Therapeutics Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Amyloidosis Therapeutics Market Share by Application: 2024 & 2031
 Figure 12. AL Amyloidosis
 Figure 13. AA Amyloidoses
 Figure 14. ATTR Amyloidoses
 Figure 15. Others
 Figure 16. Global Amyloidosis Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Amyloidosis Therapeutics Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Amyloidosis Therapeutics Sales (2020-2031) & (K Pcs)
 Figure 19. Global Amyloidosis Therapeutics Average Price (USD/Pcs) & (2020-2031)
 Figure 20. Amyloidosis Therapeutics Report Years Considered
 Figure 21. Amyloidosis Therapeutics Sales Share by Manufacturers in 2024
 Figure 22. Global Amyloidosis Therapeutics Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Amyloidosis Therapeutics Players: Market Share by Revenue in Amyloidosis Therapeutics in 2024
 Figure 24. Amyloidosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Amyloidosis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Amyloidosis Therapeutics Sales Market Share by Country (2020-2031)
 Figure 27. North America Amyloidosis Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Amyloidosis Therapeutics Sales Market Share by Country (2020-2031)
 Figure 31. Europe Amyloidosis Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Amyloidosis Therapeutics Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Amyloidosis Therapeutics Revenue Market Share by Region (2020-2031)
 Figure 39. China Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Amyloidosis Therapeutics Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Amyloidosis Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Amyloidosis Therapeutics Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Amyloidosis Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Amyloidosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Amyloidosis Therapeutics by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Amyloidosis Therapeutics by Type (2020-2031)
 Figure 61. Global Amyloidosis Therapeutics Price (USD/Pcs) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Amyloidosis Therapeutics by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Amyloidosis Therapeutics by Application (2020-2031)
 Figure 64. Global Amyloidosis Therapeutics Price (USD/Pcs) by Application (2020-2031)
 Figure 65. Amyloidosis Therapeutics Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Medicines for Alzheimer Disease Treatment Market Research Report 2025
Global Early Diagnosis Kit For Alzheimer s Disease Market Research Report 2024
Global Tauopathies Treatment Market Research Report 2025
Global Still s Disease Treatment Market Research Report 2025
Global Medicinal Gelatin Market Research Report 2024
Global Alzheimer s Drugs Market Research Report 2025
Global Pharmaceutical Asset Management Market Research Report 2025
Global Autoimmune Diseases Treatment Market Research Report 2024
Global Alzheimer s Treatment Drug Market Research Report 2024
Global Diagnostic Guidewire Market Research Report 2024
Global Alzheimer s Therapeutic Market Research Report 2024
Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024
Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024
Global Treatment Planning Software Market Research Report 2025
Alzheimer Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AI Image assisted Diagnosis Software Market Research Report 2025
Alzheimer Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Kidney Disease Drugs Market Research Report 2025
Global Drug Safety and Pharmacovigilance Service Market Research Report 2025
Global Anti Infectives Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions